The temporal mutational and immune tumour microenvironment remodelling of HER2-negative primary breast cancers

Study ID Alternative Stable ID Type
EGAS00001004953 Other

Study Description

WES and clonality characterization of different timepoints in HER2-negative primary breast cancers receiving neoadjuvant eribulin therapy.

Study Datasets 1 dataset.

Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data

Dataset ID Description Technology Samples
Temporal HER2-negative breast cancers WES
Illumina HiSeq 2500 94

Who archives the data?

There are no publications available